Urokinase Expression by Tumor Suppressor Protein P53: a Novel Role in MRNA Turnover

Overview

Journal Am J Respir Cell Mol Biol

Specialties Cell Biology
Molecular Biology

Date 2008 Apr 9

PMID 18390474

Citations 15

Authors

Praveenkumar Shetty

Thirunavukkarasu Velusamy

Yashodhar P Bhandary

Rashmi S Shetty

Ming-Cheh Liu

Sreerama Shetty

Affiliations

Soon will be listed here.

Abstract

Lung carcinoma (H1299) cells deficient in p53 (p53(-/-)) express large amounts of urokinase-type plasminogen activator (uPA) protein and uPA mRNA, and exhibit slower degradation of uPA mRNA than that of p53-expressing nonmalignant Beas2B human airway epithelial cells. Expression of p53 protein in H1299 cells, upon transfection with p53 cDNA, suppressed basal as well as uPA-induced expression of uPA protein in both conditioned media and cell lysates, and decreased the level of steady-state uPA mRNA primarily due to increased uPA mRNA turnover. Inhibition of p53 expression by RNA silencing (SiRNA) in Beas2B cells enhanced basal and uPA-mediated uPA protein and mRNA expression with stabilization of uPA mRNA. Purified p53 binds to the uPA mRNA 3' untranslated region (UTR) in a sequence-specific manner and endogenous uPA mRNA associates with p53 protein isolated from Beas2B cytosolic extracts. p53 binds to a 35-nucleotide uPA 3'UTR sequence and insertion of this sequence into beta-globin mRNA accelerates degradation of otherwise stable beta-globin mRNA. These observations confirm a new role for p53 as a uPA mRNA binding protein that down-regulates uPA mRNA stability and decreases cellular uPA expression.

Citing Articles

CSP7 Protects Alveolar Epithelial Cells by Targeting -Fibrinolytic Pathways During Lung Injuries.

Puthusseri B, Bhagavath A, Korir D, Shetty R, Johnson G, Stankowska D Am J Respir Cell Mol Biol. 2024; .

PMID: 39269467 PMC: 11707667. DOI: 10.1165/rcmb.2023-0453OC.

Shetty S, Idell S Cells. 2023; 12(4).

PMID: 36831221 PMC: 9953971. DOI: 10.3390/cells12040554.

The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer.

Barta J, Pauley K, Kossenkov A, McMahon S Carcinogenesis. 2019; 41(1):67-77.

PMID: 31067569 PMC: 7316406. DOI: 10.1093/carcin/bgz087.

Involvement of Activation of Mitogen-Activated Protein Kinase (MAPK)/Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway in Proliferation of Urethral Plate Fibroblasts in Finasteride-Induced Rat Hypospadias.

An N, Peng J, He G, Fan X, Li F, Chen H Med Sci Monit. 2018; 24:8984-8992.

PMID: 30538214 PMC: 6299793. DOI: 10.12659/MSM.911271.

Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).

Wang L, Zhang Y, Wang W, Zhu Y, Chen Y, Tian B PLoS One. 2017; 12(8):e0184110.

PMID: 28854261 PMC: 5576696. DOI: 10.1371/journal.pone.0184110.

References

Shetty S, Rao G, Cines D, Bdeir K . Urokinase induces activation of STAT3 in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006; 291(4):L772-80. DOI: 10.1152/ajplung.00476.2005. View

Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco M . Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods. 2002; 26(2):182-90. DOI: 10.1016/S1046-2023(02)00021-X. View

Shetty S, Idell S . Post-transcriptional regulation of urokinase mRNA. Identification of a novel urokinase mRNA-binding protein in human lung epithelial cells in vitro. J Biol Chem. 2000; 275(18):13771-9. DOI: 10.1074/jbc.275.18.13771. View

Sisson T, Hattori N, Xu Y, Simon R . Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther. 1999; 10(14):2315-23. DOI: 10.1089/10430349950016960. View

Shetty S, Kumar A, Idell S . Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol. 1997; 17(3):1075-83. PMC: 231832. DOI: 10.1128/MCB.17.3.1075. View

Sitrin R, Todd 3rd R, Albrecht E, Gyetko M . The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest. 1996; 97(8):1942-51. PMC: 507264. DOI: 10.1172/JCI118626. View

Chapman H . Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol. 1997; 9(5):714-24. DOI: 10.1016/s0955-0674(97)80126-3. View

Jiang Y, Pannell R, Liu J, Gurewich V . Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. Blood. 1996; 87(7):2775-81. View

Lane D . Curing cancer with p53. N Engl J Med. 2004; 350(26):2711-2. DOI: 10.1056/NEJMcibr041288. View

10.

Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A . The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost. 2005; 93(2):205-11. DOI: 10.1160/TH04-09-0592. View

11.

Chandrasekar N, Mohanam S, Gujrati M, Olivero W, Dinh D, Rao J . Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene. 2003; 22(3):392-400. DOI: 10.1038/sj.onc.1206164. View

12.

Shetty S, Idell S . Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem. 2001; 276(27):24549-56. DOI: 10.1074/jbc.M101605200. View

13.

Shetty S, Idell S . Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro. Mol Cell Biochem. 1999; 199(1-2):189-200. DOI: 10.1023/a:1006914800447. View

14.

Levine A . p53, the cellular gatekeeper for growth and division. Cell. 1997; 88(3):323-31. DOI: 10.1016/s0092-8674(00)81871-1. View

15.

Shetty S, Kumar A, Johnson A, Idell S . Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev. 1995; 5(4):307-14. DOI: 10.1089/ard.1995.5.307. View

16.

Peyrat J, Vanlemmens L, Fournier J, Huet G, Revillion F, Bonneterre J . Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers. Clin Cancer Res. 1998; 4(1):189-96. View

17.

Dvorak H . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650-9. DOI: 10.1056/NEJM198612253152606. View

18.

Kunz C, Pebler S, Otte J, von der Ahe D . Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res. 1995; 23(18):3710-7. PMC: 307270. DOI: 10.1093/nar/23.18.3710. View

19.

Mazar A, Henkin J, Goldfarb R . The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis. 2003; 3(1):15-32. DOI: 10.1023/a:1009095825561. View

20.

Lundberg A, Weinberg R . Control of the cell cycle and apoptosis. Eur J Cancer. 2000; 35(14):1886-94. DOI: 10.1016/s0959-8049(99)00292-0. View